Holen Sie sich die Stockscreener-App
1.87
1.84%
-0.03
Schlusskurs vom Vortag:
$1.90
Offen:
$1.97
24-Stunden-Volumen:
722.77K
Relative Volume:
0.13
Marktkapitalisierung:
$279.01M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.07M
KGV:
-0.1337
EPS:
-13.99
Netto-Cashflow:
$-12.56M
1W Leistung:
-25.40%
1M Leistung:
-1.84%
6M Leistung:
+145.39%
1J Leistung:
-7.21%
1-Tages-Spanne:
$1.86
$1.97
1-Wochen-Bereich:
$1.845
$2.55
52-Wochen-Spanne:
$0.53
$2.64
Palisade Bio Inc Stock (PALI) Company Profile
Firmenname
Palisade Bio Inc
Sektor
Branche
Telefon
(858) 704-4900
Adresse
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD
Vergleichen Sie PALI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PALI
Palisade Bio Inc
|
1.87 | 283.49M | 0 | -14.07M | -12.56M | -13.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
471.19 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
810.84 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
408.64 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
815.91 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.19 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Palisade Bio Inc Stock (PALI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-29 | Eingeleitet | Piper Sandler | Overweight |
Palisade Bio Inc Aktie (PALI) Neueste Nachrichten
B.Riley initiates coverage on Palisade Bio stock with Buy rating - Investing.com Australia
How Palisade Bio Inc. (7NS0) stock reacts to Fed tighteningShort Setup & Consistent Profit Trading Strategies - ulpravda.ru
Can Palisade Bio Inc. stock deliver consistent earnings growthTrade Risk Report & Expert Approved Momentum Ideas - ulpravda.ru
What is the fair value of Palisade Bio Inc. stock nowEarnings Growth Summary & Verified Momentum Stock Ideas - ulpravda.ru
Crohn’s & Colitis Foundation invests up to $500,000 in Palisade Bio By Investing.com - Investing.com Nigeria
How currency fluctuations impact Palisade Bio Inc. stockEx-Dividend Date Alerts & Low Entry Cost Investment - ulpravda.ru
Exit Recap: Will Palisade Bio Inc stock attract more institutional investors2025 AllTime Highs & High Conviction Buy Zone Alerts - moha.gov.vn
Palisade Bio Announces Strategic Investment from Crohn's & Colitis Foundation to Support Development of PALI-2108 for Ulcerative Colitis and Crohn's Disease - Quiver Quantitative
Palisade Bio Announces Strategic Equity Investment from the - GlobeNewswire
Will Palisade Bio Inc. stock benefit from sector rotation2026 world cup usa national team third place match star players set piece tactics winner prediction expert opinion - ulpravda.ru
Palisade Bio (PALI) soars 5% ahead of clinical trial results - MSN
Wall Street Zen Upgrades Palisade Bio (NASDAQ:PALI) to "Hold" - MarketBeat
Risk Report: What is the fair value of Palisade Bio Inc stock now2025 Major Catalysts & Intraday High Probability Setup Alerts - moha.gov.vn
Palisade Bio Inc. (PALI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Analysts Are Bullish on These Healthcare Stocks: Palisade Bio (PALI), Centessa Pharmaceuticals (CNTA) - The Globe and Mail
Palisade Bio, Inc. (NASDAQ:PALI) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Palisade Bio (NASDAQ:PALI) Stock Rating Upgraded by Clear Str - MarketBeat
9,119,152 Common Stock of Palisade Bio, Inc. are subject to a Lock-Up Agreement Ending on 31-DEC-2025. - MarketScreener
Certain Stock Options of Palisade Bio, Inc. are subject to a Lock-Up Agreement Ending on 31-DEC-2025. - marketscreener.com
Certain Restricted Stock Units of Palisade Bio, Inc. are subject to a Lock-Up Agreement Ending on 31-DEC-2025. - MarketScreener
Certain Warrants of Palisade Bio, Inc. are subject to a Lock-Up Agreement Ending on 31-DEC-2025. - marketscreener.com
Palisade Bio receives patent approval in Japan for IBD drug PALI-2108 - Investing.com Nigeria
Palisade Bio Says Japan Grants Patent for Composition of PALI-2108 - MarketScreener
New gut-targeted drug gains key patent in Japan for severe bowel disease - Stock Titan
Palisade Bio (NASDAQ:PALI) Upgraded at Piper Sandler - MarketBeat
Palisade Bio Announces Granting of Japanese Patent Covering - GlobeNewswire
Palisade Bio stock initiated with Buy rating at Clear Street on IBD drug potential - Investing.com
Palisade Bio Appoints New VP to Drive Further Growth - StocksToTrade
DigitalBridge Group, Eightco Holdings, Palisade Bio And Other Big Stocks Moving Higher On Monday - Benzinga
PALI’s Strategic Move: What’s Next? - timothysykes.com
Piper Sandler initiates Palisade Bio stock with Overweight rating on IBD drug By Investing.com - Investing.com Nigeria
Piper Sandler initiates Palisade Bio stock with Overweight rating on IBD drug - Investing.com
Palisade Bio (PALI) Soars 5% Ahead of Clinical Trial Results - Finviz
10 Stocks Lighting Up Market Ahead of Christmas - Insider Monkey
Palisade Bio: Gut Prodrug For IBD With Catalysts - Seeking Alpha
Palisade Bio (PALI) upgraded to buy: Here's what you should know - MSN
Aug Summary: Is Palisade Bio Inc stock ready for breakout2025 Macro Impact & AI Enhanced Market Trend Forecasts - moha.gov.vn
Published on: 2025-12-21 10:03:36 - Улправда
Why analysts remain bullish on Palisade Bio Inc. stock2025 Top Gainers & High Accuracy Investment Signals - Улправда
What earnings margins imply for Palisade Bio Inc. (7NS0) stockPortfolio Gains Summary & Weekly Top Stock Performers List - Улправда
Palisade Bio (NASDAQ:PALI) Stock Rating Lowered by Wall Street Zen - MarketBeat
Can Palisade Bio Inc. stock deliver surprise earnings beatWatch List & High Return Stock Watch Alerts - Улправда
How Palisade Bio Inc. stock reacts to bond yields2025 Performance Recap & Daily Entry Point Trade Alerts - Улправда
Is Palisade Bio Inc. stock a good choice for value investorsJuly 2025 Pullbacks & Low Risk Investment Opportunities - Улправда
Palisade Bio (PALI) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Aug Macro: How geopolitical risks impact Palisade Bio Inc. (7NS0) stock2025 Support & Resistance & Free High Accuracy Swing Entry Alerts - Улправда
Is Palisade Bio Inc. stock near bottom after decline2025 Trade Ideas & Smart Allocation Stock Tips - Улправда
Aug Final Week: Will Palisade Bio Inc. (7NS0) stock benefit from Fed rate cutsJuly 2025 Trade Ideas & Stepwise Trade Execution Plans - Улправда
How interest rate cuts could boost Palisade Bio Inc. stockTrade Risk Assessment & Capital Protection Trading Alerts - Улправда
Finanzdaten der Palisade Bio Inc-Aktie (PALI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):